Kukje to step forward for Cefuroxime Axcetyl export to Europe.

Published: 2004-06-14 06:57:00

Updated: 2004-06-14 06:57:00

Kukje obtained CEP Certificate from EDQM (European Directorate for the Quality of Medicines) in France at the early of June for Cefuroxime Axcetyl, an oral antibiotic raw material, which may put a stepping stone for the overseas business especially in 20 European nations including Germany, France...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK